News

SEC Filings

Document Details

Filing Date
March 8, 2024
Document Date
March 8, 2024
Form Description
Solicitation/recommendation statements
Filing Group
Mergers & Acquisitions
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com